Read More Pharma Industry News Viatris launches $1.65bn Pacira tender, but 11-cent share-price gap limits potential upside Viatris Inc. (NASDAQ: VTRS) has formally launched its $36.50-per-share cash tender offer for Pacira BioSciences, Inc. (NASDAQ: PCRX),… byPallavi MadhirajuNovember 1, 2026